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Abstract
Nicotine, a component of tobacco, is highly addictive but possesses beneficial properties such as
cognitive improvements and memory maintenance. Involved in these processes is the neuronal nicotinic
acetylcholine receptor (nAChR) alpha7, whose activation triggers depolarization, intracellular signaling
cascades, and synaptic plasticity underlying addiction and cognition. It is therefore important to
investigate intracellular mechanisms by which a cell regulates alpha7 nAChR activity. We have
examined the role of phosphorylation by combining molecular biology, biochemistry, and
electrophysiology in SH-SY5Y neuroblastoma cells, Xenopus oocytes, rat hippocampal interneurons,
and neurons from the supraoptic nucleus, and we found tyrosine phosphorylation of alpha7 nAChRs.
Tyrosine kinase inhibition by genistein decreased alpha7 nAChR phosphorylation but strongly increased
acetylcholine-evoked currents, whereas tyrosine phosphatase inhibition by pervanadate produced
opposite effects. Src-family kinases (SFKs) directly interacted with the cytoplasmic loop of alpha7
nAChRs and phosphorylated the receptors at the plasma membrane. SFK inhibition by PP2
[4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine] or SU6656
(2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-indole-5-sulfona
mide) increased alpha7 nAChR-mediated responses, whereas expression of active Src reduced alpha7
nAChR activity. Mutant alpha7 nAChRs lacking cytoplasmic loop tyrosine residues because of alanine
replacement of Tyr-386 and Tyr-442 were more active than wild-type receptors and insensitive to kinase
or phosphatase inhibition. Because the amount of surface alpha7 receptors was not affected by kinase or
phosphatase inhibitors, these data show that functional properties of alpha7 nAChRs depend on the
tyrosine phosphorylation status of the receptor and are the result of a balance between SFKs and
tyrosine phosphatases. These findings reveal novel regulatory mechanisms that may help to understand
nicotinic receptor-dependent plasticity, addiction, and pathology.
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Nicotine, a component of tobacco, is highly addictive but possesses beneficial properties such as cognitive improvements and memory
maintenance. Involved in these processes is the neuronal nicotinic acetylcholine receptor (nAChR) 7, whose activation triggers depo-
larization, intracellular signaling cascades, and synaptic plasticity underlying addiction and cognition. It is therefore important to
investigate intracellular mechanisms by which a cell regulates 7 nAChR activity. We have examined the role of phosphorylation by
combiningmolecular biology, biochemistry, and electrophysiology in SH-SY5Y neuroblastoma cells, Xenopus oocytes, rat hippocampal
interneurons, and neurons from the supraoptic nucleus, and we found tyrosine phosphorylation of7 nAChRs. Tyrosine kinase inhibi-
tion by genistein decreased 7 nAChR phosphorylation but strongly increased acetylcholine-evoked currents, whereas tyrosine phos-
phatase inhibition by pervanadate produced opposite effects. Src-family kinases (SFKs) directly interacted with the cytoplasmic loop of
7 nAChRs and phosphorylated the receptors at the plasma membrane. SFK inhibition by PP2 [4-amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine] or SU6656 (2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-1H-indol-2-yl)methylene]-1H-
indole-5-sulfonamide) increased 7 nAChR-mediated responses, whereas expression of active Src reduced 7 nAChR activity. Mutant
7 nAChRs lacking cytoplasmic loop tyrosine residues because of alanine replacement of Tyr-386 and Tyr-442 were more active than
wild-type receptors and insensitive to kinase or phosphatase inhibition. Because the amount of surface7 receptors was not affected by
kinase or phosphatase inhibitors, these data show that functional properties of 7 nAChRs depend on the tyrosine phosphorylation
status of the receptor and are the result of a balance between SFKs and tyrosine phosphatases. These findings reveal novel regulatory
mechanisms that may help to understand nicotinic receptor-dependent plasticity, addiction, and pathology.
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Introduction
Protein phosphorylation and dephosphorylation are key mecha-
nisms to regulate the activity of integral membrane proteins such
as ion channels. In brain, tyrosine phosphorylation directs syn-
aptic plasticity, as illustrated by the role of Src-family kinases
(SFKs) in hippocampal long-term potentiation (LTP) and spatial
learning (Grant et al., 1992; Lu et al., 1998). Although such LTP
involves phosphorylation of glutamate receptors (Lu et al., 1998),
the hippocampus and other brain areas are rich in other ligand-
gated channels such as neuronal nicotinic acetylcholine receptors
(nAChRs) (Jones et al., 1999). However, regulatory mechanisms
of these brain nAChRs such as phosphorylation are still essen-
tially unknown.
One of the most prominent nAChRs is the homomeric 7
receptor, which acts in synaptic plasticity underlying cognitive
processing and addiction (Dajas-Bailador and Wonnacott,
2004). In hippocampus, 7 nAChRs are highly expressed in
GABAergic interneurons in which they mediate cholinergic syn-
aptic input (Alkondon et al., 1998; Frazier et al., 1998b) and
regulate inhibition within the hippocampal network (Alkondon
et al., 1997; Jones and Yakel, 1997). Activation of these 7
nAChRs blocks concurrent short-term potentiation and LTP in-
duction in the pyramidal cells innervated by the interneurons (Ji
et al., 2001). Inhibition of pyramidal neurons by postsynaptic 7
nAChRs on interneurons also underlies hippocampal auditory
gating (Martin et al., 2004). Nicotine-activated presynaptic 7
receptors, because of their high calcium permeability, increase
glutamate release in the ventral tegmental area, leading to LTP in
dopaminergic neurons, a model for nicotine addiction (Mans-
velder and McGehee, 2000)
7 nAChRs are linked to many normal and pathological con-
ditions. They are important in working memory formation,
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arousal, and attention (Levin, 2002), nicotine addiction, and
nicotine-induced reversal of age-related memory deficits (Pic-
ciotto and Zoli, 2002). Their role in hippocampal auditory gating
has linked the receptors to schizophrenia (Jones et al., 1999;Mar-
tin et al., 2004). The observation that 7 nAChR activation leads
to neuroprotection against A-induced neurotoxicity (Kihara et
al., 2001; Shaw et al., 2002), together with many other findings
(Liu et al., 2001; Picciotto and Zoli, 2002), suggests that the re-
ceptor may play a key role in Alzheimer’s disease.
These diverse physiological roles of7 nAChRs are thought to
reflect local calcium signaling that triggers downstream path-
ways, such as activation of cAMP response element-binding pro-
tein, protein kinase A, and extracellular signal-regulated kinase
1/2 (Dajas-Bailador et al., 2002; Hu et al., 2002), or phosphatidyl-
inositol 3-kinase, Akt, and Bcl-2 (Kihara et al., 2001). Suchmech-
anisms result in expression of genes important in synaptic plas-
ticity or cell survival (Berg and Conroy, 2002; Dajas-Bailador and
Wonnacott, 2004). However, no signaling, scaffolding, or an-
choring proteins that directly interact with 7 receptors have as
yet been identified (Huh and Fuhrer, 2002).
We began addressing how phosphorylation and intracellular
proteins regulate 7 nAChRs. Our results reveal that a balance
between kinases and phosphatases regulates tyrosine phosphor-
ylation of the receptors at the cell surface. SFKs are part of these
kinases, because SFKs bind and phosphorylate 7 receptors and
regulate their activity. Interestingly, dephosphorylated 7
nAChRs cause increased ACh-evoked current, whereas phos-
phorylated receptors are less active, showing that tyrosine phos-
phorylation and SFKs negatively regulate receptor activity.
Materials andMethods
Culture of SH-SY5Y 7 cells and isolation of -bungarotoxin-binding (to-
tal) 7 receptors. SH-SY5Y neuroblastoma cells that were stably trans-
fected with human 7 subunits (SH-7) were maintained in DMEM/
Ham’s F-12 (1:1) media containing 10% fetal calf serum and 100 g/ml
G418 and were split every 3–4 d. Isolation of -bungarotoxin (-BT)-
binding 7 receptors was done as described previously for muscle
nAChRs from myotubes (Fuhrer and Hall, 1996; Mittaud et al., 2001).
Briefly, SH-7 cells were extracted in lysis buffer containing 1% NP-40,
30 mM triethanolamine, 50 mM NaCl, 5 mM EDTA, 5 mM EGTA, 50 mM
NaF, 2 mM Na-orthovanadate, 1 mM N-ethylmaleimide, 1 mM Na-
tetrathionate, 50 M phenylarsine-oxide, 10 mM p-nitrophenylphos-
phate, 25g/ml aprotinin, 25g/ml leupeptin, 2mMNa-orthovanadate,
and 1mM PMSF. Cell lysates were cleared by centrifugation (refrigerated
Eppendorf centrifuge, 14,000 rpm, 5 min at 4°C; Eppendorf Scientific,
Westbury, NY), and supernatants were incubated with 200 nM biotinyl-
ated -BT (Invitrogen, Eugene, OR). Streptavidin–agarose beads (In-
vitrogen)were added to precipitate7 nAChRs.Nonspecific bindingwas
determined by applying 10M free (nonbiotinylated) -BT before addi-
tion of biotinylated -BT. After precipitation, bead pellets were washed,
and bound proteins were eluted and subjected to SDS-PAGE and West-
ern blot analysis. 7 receptors were detected using goat polyclonal anti-
bodies raised against the 7 C terminus (1:200 dilution; Santa Cruz
Biotechnology, Santa Cruz, CA) (Drisdel and Green, 2000) or rabbit
polyclonal antibodies raised against the 7 N terminus (1:1000 dilution;
Abcam, Cambridge, UK). Both antibodies gave the same results. 7 re-
ceptors isolated in this manner reflect the total cellular pool of 7
nAChRs. In our figures, -BT-precipitations (Tox-P) represent such to-
tal 7 receptor isolations, unless specified as surface or intracellular pre-
cipitation (see below).
Isolation of surface and intracellular 7 nAChRs. To precipitate 7
receptors from the surface of SH-7 cells, we used a protocol established
previously for muscle nAChRs in myotubes (Moransard et al., 2003).
Briefly, intact SH-7 cells were incubated in media with 200 nM biotin-
ylated-BT for 45min in the culture incubator. Nonspecific bindingwas
determined by applying 10 M free (nonbiotinylated) -BT 30–45 min
before adding biotinylated -BT. Cells were washed twice with PBS and
lysed as described above. Streptavidin–agarose beads were added to pre-
cipitate surface AChRs.
Intracellular7 receptorswere precipitated as described previously for
muscle nAChRs (Moransard et al., 2003). Briefly, intact SH-7 cells were
preincubated for 45 min with 1 M free -BT in media in the culture
incubator to block surface receptors. Cells werewashed twicewith PBS to
remove unbound-BT and lysed. Biotinylated-BT (200 nM)was added
to lysates, followed by streptavidin–agarose beads, to isolate intracellular
7 nAChRs.
In these preparations, surface and intracellular 7 receptors were ad-
ditive to yield total receptors (K. H. Huh and C. Fuhrer, unpublished
observations).
Treatment of SH-7 cells with pervanadate and kinase inhibitors. Per-
vanadate was prepared as described previously (Meier et al., 1995) and
used at a standard concentration of 50 M in culture medium on SH-7
cells for 20 min before lysis. To block tyrosine kinases, cells were pre-
treated with genistein (100 or 250 M for 10 min), PP2 [4-amino-5-(4-
chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine] (1 or 10M for 10
min (Smith et al., 2001), CGP77675; [10 M for 45–90 min (Missbach et
al., 1999)], or 2,3-dihydro-N,N-dimethyl-2-oxo-3-[(4,5,6,7-tetrahydro-
1H-indol-2-yl)methylene]-1H-indole-5-sulfonamide [SU6656; a substi-
tuted 5,7-diphenyl-pyrrolo[2,3-d]pyrimidine [10 M for 30 min (Blake
et al., 2000)] before addition of pervanadate (50 M for 20 min). After
these treatments, cells were lysed, and 7 receptors were precipitated as
described above. Tyrosine phosphorylation of 7 receptors and SFK
association were evaluated by Western blotting.
Preparation of rat brain membrane homogenates. Whole brains from
postnatal day 5 (P5) rats or forebrains from P30 rats (Lewis) were ho-
mogenized in lysis buffer containing 1% NP-40, DTT (2 M), and pep-
statin (5g/ml). Homogenizedmaterial was incubated at 4°C for 30min
for lysis and centrifuged at 55,000 rpm for 20min. Cleared soluble lysates
were incubated with -BT directly coupled to Sepharose beads (Fuhrer
andHall, 1996) for 2 h to isolate7 receptors. For determination of nonspe-
cific binding, these lysates were preincubated with 10 M free -BT for 30
min before incubation with -BT-coupled beads. After incubation, beads
were processed as described above. Phosphorylation of the receptors and
association of SFKs were determined byWestern blot analysis.
Additional antibodies and Western blot analysis. Tyrosine phosphory-
lation was detected using phosphotyrosine-specific antibodies (4G10;
Upstate Biotechnology, Lake Placid, NY). Antibodies against Src-family
kinases [pan-Src antibodies (Src-CT), Lyn and Fyn] and glutathione
S-transferase (GST) were purchased from Santa Cruz Biotechnology
(Fuhrer andHall, 1996). Specific antibodies against Srcwere fromOncogene
Sciences (Boston, MA) (Fuhrer and Hall, 1996). Blots were probed with
antibodies in 4G10 blocking solution (5%BSA, 0.5%NP-40 in TBST (0.1%
Tween-20, 20 mM Tris, 137 mM NaCl, pH 7.6)) or in 5% milk in TBST.
Proteins were detected by chemiluminescence using a kit from Amersham
Biosciences (Little Chalfont, UK). For reprobing, blots were stripped by
incubating them for 20min in 200mM glycine, 0.1% Tween 20, pH 2.5.
Determination of putative phosphorylation sites. The Netphos 2.0 soft-
ware (Blom et al., 1999) (http://www.cbs.dtu.dk/services/NetPhos/) was
used to determine putative phosphorylation sites in the 7 protein se-
quence. Tyrosines known to be phosphorylated in nAChR subunits from
Torpedo californica (Wagner et al., 1991) were aligned with human 7
nAChRs to further analyze phosphorylation sites. Combination of soft-
ware prediction and sequence alignment data, also using 7 sequences
from a variety of species, was used to predict phosphorylation sites in
human 7 receptors.
DNA constructs. Sequences encoding the cytoplasmic loop (amino ac-
ids 325–459; GST-7loop) or the C-terminal region including the fourth
transmembrane domain (amino acids 461–502; GST-7TM4CT) of the
human 7 receptor were inserted in frame into pGEX-2T vector encod-
ing glutathione-S-transferase (GST). Tyrosines 386 or 442 in GST-
7loop were mutated to alanine using QuikChange site-directed mu-
tagenesis kit (Stratagene, La Jolla, CA) to generate GST-7(A386), GST-
7(A442), and GST-7(A386/442). Fusion proteins were expressed in
DH5 bacterial strain and purified using glutathione–Sepharose beads as
described previously (Fuhrer andHall, 1996).Mutant7 2Y-A receptors
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were constructed accordingly, usingQuikChange site-directedmutagen-
esis kit and the full-length human 7 sequence in a pcDNA3-based ex-
pression vector (TOPO vector). Expression vectors for viral Src (vSrc)
and vSrc-KD (kinase-dead vSrc) were kindly provided by Dr. Todd
Holmes (New York University, New York, NY) (Nitabach et al., 2001,
2002).
SFK association and in vitro phosphorylation of GST-7 fusion proteins.
To study interactionwith SFKs (see Fig. 7d), purified glutathione–Sepha-
rose bead-bound fusion proteins were added for 2 h to SH-7 lysates
prepared as described above. After washing with high- and low-salt wash
buffers (Fuhrer and Hall, 1996), the resulting precipitates were used to
evaluate the association of SFKs by Src-CT Western blotting.
To examine tyrosine phosphorylation of fusion proteins by SFKs from
SH-7 cells in vitro (see Fig. 8c), cells were pretreated with pervanadate
alone or in combination with PP2. Lysates were incubated with purified
GST-7loop fusion proteins, and beads were precipitated and washed.
Beads were incubated in phosphorylation assay buffer containing 3 mM
ATP (20 mM Tris, pH 7.4, 10 mMMgCl2, 2 mMNa-orthovanadate, and 1
mM PMSF) for 15 min at 37°C or 4°C. Beads were centrifuged at 4°C to
remove supernatant, and attached proteins were analyzed by SDS-PAGE
and Western blot.
To examine tyrosine phosphorylation of fusion proteins by Src kinase
in vitro (see Fig. 8d), purified GST-7loop(WT), GST-7(A386), GST-
7(A442), andGST-7(A386/442) proteinswere incubatedwith 1.5Uof
purified human Src kinase (c-Src; Upstate Biotechnology). Incubations
were performed in phosphorylation assay buffer containing 10 M ATP
(20 mM HEPES, 10 mM MgCl2, and 100 mM NaCl) as described above.
LabelingwithAlexa 488–-BT and fluorescencemicroscopy. SH-7 cells
were grown for 5 d on L-lysine- and laminin-coated plates in medium
supplemented with 20 M all-trans-retinoic acid to promote neural dif-
ferentiation. Medium was exchanged by media lacking fetal bovine se-
rum, and 20 ng/ml BDNF was added for 5 d. To stain cells, 100 nM Alexa
488-coupled -BT (Molecular Probes) was added for 1 h. Nonspecific
binding was assessed by incubating cells in 10 M unlabeled -BT or 1
mM nicotine 10 min before and during the labeling with Alexa 488–-
BT. Cells were washed in buffer containing 4,6-diamidino-2-
phenylindole (DAPI) to label nuclei, fixed with cryofix, andmounted on
coverslips. Conventional fluorescence imaging was done using a Zeiss
(Oberkochen, Germany) Axioskop 2microscope equippedwith a cooled
Hamamatsu (Schu¨pfen, Switzerland) Orca digital camera, using 1000
magnification. Alexa 488–-BT detected clusters on cell somata and
processes, and this signal was abolished by unlabeled -BT or nicotine
(data not shown), confirming that it corresponds to 7 receptors.
Oocyte preparation and cDNA injection. Xenopus oocytes were isolated
and prepared as described previously (Eisele et al., 1993; Krause et al.,
1998). Two nanograms of expression vectors containing the various
cDNAs were injected into the oocyte nucleus. Each oocyte was injected
with TOPO expression vector containingwild-type human7 ormutant
7 2Y-A receptor DNA. For experiments with vSrc kinase, the ratio was
10:1 for7 versus vSrc or vSrc-KDDNA.Oocytes were incubated for 2–3
d at 18°C in Barth’s solution that contained 88 mM NaCl, 1 mM KCl, 2.4
mM NaHCO3, 10 mM HEPES, 0.82 mM MgSO47H2O, 0.33 mM
Ca(NO3)24H2O, and 0.41 mM CaCl26H2O, at pH 7.4, supplemented
with 20 g/ml kanamycine, 100 U/ml penicillin, and 100 g/ml
streptomycin.
Binding assay with 125I--BT.Oocytes labeling experiments were per-
formed 2 d after DNA injection. Oocytes were incubated for 1 h in either
control solution or the presence of 10 M genistein, 125I--BT (Amer-
sham Biosciences, Arlington Heights, IL) was added at a final concentra-
tion of 10 nM, and cells were incubated for 1 h. After labeling, oocytes
were individually washed five times in cold OR2 buffer (for buffer ingre-
dients, see next paragraph). To prevent adsorption of the toxin on the
plastic, all solutions were supplemented with 20g/ml BSA. Each oocyte
was then placed in a vial, and the amount of radioactive 125I--BT was
determined using a gamma counter (2min countingmode). Nonspecific
binding was determined using 1 M unlabeled -BT (1 h preincubation
and during radioactive labeling). Thirty oocytes were tested in each con-
dition. Expression rates in oocytes are known to vary considerably (Yo-
shii et al., 1987; Yu et al., 1991; Cruz-Martin et al., 2001). For this reason,
only cells displaying a labeling superior to nonspecific binding were used
for the computation, and mean nonspecific values were subtracted. Us-
ing a 125I--BT standard, the amount of bound toxin was calculated in
femtomoles per oocyte.
To label SH-7 cells, cells were grownon 35mmdishes to a confluence
of 60–100% and incubated with 10 nM 125I--BT for 1 h in cell medium.
Inhibitor treatments were as in the corresponding biochemical experi-
ments (100 m genistein was added for 30 min, 10 M PP2 for 90 min,
and 50 M pervanadate for 20 min before 125I--BT), and inhibitors
were present during the radioactive labeling. Nonspecific binding was
determined by adding 1M unlabeled toxin 1 h before and during radio-
active labeling. Cells were then washed twice with ice-cold PBS and sol-
ubilized in lysis buffer as described above (paragraph about precipitation
with biotin--BT). Lysates were analyzed in a gamma counter, and ali-
quots were taken for protein determination assays. Radioactive signals
were robust (30,000–100,000 cpm), the nonspecific backgroundwas low
(5–10%), andprotein levels did not vary between individual cell lysates in
an experiment. Cell treatments at 37°C or 21°C produced the same
results.
Oocyte electrophysiological recordings. Cells were continuously super-
fused withOR2 that contained 82.5mMNaCl, 2.5mMKCl, 5mMHEPES,
2.5 mM CaCl22H2O, and 1 mM MgCl2.6H2O, pH 7.4, and 0.5 M atro-
pine was added to prevent possible activation of endogenous muscarinic
receptors. All drugs were diluted in theOR2medium immediately before
the experiment. Bovine serum albumin (20 mg/ml) was added to the
perfusion anddrugmedia to prevent adsorption of the compounds to the
plastic. Electrophysiological recordings were performed using a two-
electrode voltage clamp (GENECLAMP amplifier; Axon Instruments,
Forster City, CA), and cells were held at100mV. The flow rate was6
ml/min, and the volume of the chamber was 100 l to allow rapid
solution exchange.
To minimize contamination by endogenous Ca2-activated chloride
channels, oocytes were incubated with BAPTA-AM (100 M) for at least
3 h before recording. For preincubation experiments, oocytes were incu-
bated with drugs diluted in Barth’s medium in the presence of
BAPTA-AM (100 M). Preincubation periods of 1–2 h were used for
genistein and inactive genistein and of 30–60 min for pervanadate. Re-
cordings performed after preincubations were done in the presence of an
identical drug concentration to prevent drug washout. To limit possible
direct drug effect on the7 receptor, the drug applicationwas stopped 1 s
before and restarted immediately after the acetylcholine test pulse.
For oocyte data analysis, dose–response curves were fit using the em-
pirical Hill equation: Y  1/1  (EC50/x)nˆH, where y is the fraction of
remaining current, EC50 is the concentration of half-inhibition, nH is the
apparent cooperativity, and x is the agonist concentration.
Values indicated throughout the text are given with their respective
SEM. For statistical analysis, we used the unpaired, two-tailed Student’s t
test.
Genistein, inactive genistin (Igen), and sodium orthovanadate were
purchased from Sigma (St. Louis, MO), and PP2, PP3 (4-amino-7-
phenylpyrazol[3,4-d]pyrimidine), and SU6656 were from Calbiochem
(Juro, Lucern, Switzerland). Stock solutions of genistein and its inactive
analog were made in DMSO and diluted to their final concentration in
OR2. The maximal concentration of DMSO applied to oocytes was 1%
(v/v), a concentration that had no effect on the oocyte restingmembrane
conductance or on the ACh-evoked responses. Pervanadate was pre-
pared as described previously (Meier et al., 1995).
Electrophysiological recordings in SH-7 cells. Cells were maintained in
culture using the same conditions as described for the biochemical ex-
periments. Two to 4 d before the electrophysiological assays, cells were
seeded into 35 mm dishes. Cells were washed three times with artificial
CSF (in mM: 130 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, and 10 HEPES, pH
adjusted to 7.4 with NaOH) and placed on the stage of an inverted Ax-
iovert 100 microscope (Zeiss). Whole-cell recording patches were
achieved using borosilicate tubes pulled with a BB-CH-PC (Mecanex,
Nyon, Switzerland). Electrodes were filled with an intracellular solution
(in mM: 130 K-gluconate, 5 NaCl, 2 MgCl2, 10 HEPES, and 5 EGTA, pH
adjusted to 7.4 with KOH) and had a typical resistance of 2–3 M.
Currents were recorded using an AxoPatch 200B (Axon Instruments)
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digitized with a card PCI-1200 fromNational Instruments (Austin, TX),
and data were stored on a Macintosh computer (Apple Computers, Cu-
pertino, CA), usingMacDatac software. Drugs were applied using a theta
tube mounted on a piezo quartz (Physiks Instruments, Walbronn Ger-
many), as described previously (Buisson and Bertrand, 2001), that al-
lowed very fast drug delivery. Solution exchanges were controlled by
electromagnetic valves driven by the data acquisition system.
Preparation of brain slices. Two- to 5-week-old rats [Sprague Dawley;
Charles River Wiga (Sulzfeld, Germany), Iffa Credo (L’Arbresle,
France)] were anesthetized (pentobarbital, 50 mg/kg, i.p.) and decapi-
tated in accordance with the rules of the Swiss Federal Veterinary Office.
The brain was rapidly removed, and coronal hypothalamic or transverse
hippocampal slices, 300–400 m thick, were prepared as described pre-
viously (Zaninetti et al., 2000; Ogier and Raggenbass, 2003). A single
slice, containing either the supraoptic nucleus or the CA1 region of the
hippocampus, was transferred to a thermoregulated recording chamber
(32–33°C), submerged and continuously perfused with a solution con-
taining 135 mM NaCl, 15 mM NaHCO3, 5 mM KCl, 1 mM MgCl2, 2 mM
CaCl2, and 10mM glucose and saturated with a gas mixture composed of
95%O2/5%CO2, pH 7.3–7.4. The perfusion solution was supplemented
with 2 M atropine to prevent activation of muscarinic receptors. The
recording chamber was set on the stage of an Eclipse E600FN (Nikon,
Tokyo, Japan), equipped with a 40, 0.8 numerical aperture water-
immersion objective and differential interference contrast optics, and
neurons were visualized using an infrared-sensitive video camera
(C2400-07; Hamamatsu).
Whole-cell recordings in brain slices. Patch pipettes were pulled from
borosilicate glass capillaries (Harvard Apparatus, Edenbridge, UK) and
had tip resistances of 3–6 M. The patch pipette solution contained the
following (in mM): 140 K-gluconate, 10 KCl, 10 HEPES, 4 MgCl2, 0.1
BAPTA, 2Na2-ATP, and 0.4Na2-GTP, pH7.2–7.3. The osmolarity of the
pipette solution was 285–310 mOsm. Gigaohm seals were made by ap-
plying a slight negative pressure to the back of the pipette, and access to
the whole-cell configuration was achieved by further applying negative
pressure. Access resistance was 10–25 M. Neurons were voltage
clamped at 70 mV, and current signals were amplified using an Axo-
patch 200A (Axon Instruments). They were low-pass filtered at 2 kHz
and digitized at 5 kHz. ACh (0.2–1 mM) was applied by pressure ejection
from patch-type pipette (30 psi, 40–400 ms) positioned within 10–20
m from the soma of the recorded neuron.
Results
Tyrosine phosphorylation of 7 nAChRs
nAChRs can be divided in two main groups according to their
sensitivity to -BT (Dani, 2001). The most abundant receptor
subtype of the-BT-sensitive group is the7 receptor, composed
of five identical subunits (Berg andConroy, 2002). To investigate
whether 7 nAChRs are phosphorylated on tyrosine residues, we
took advantage of SH-SY5Y cells, a human neuroblastoma cell
line used for studying nicotinic receptors. The cells express low
levels of functional 7 receptor channels, which specifically bind
-BT (Peng et al., 1994; Puchacz et al., 1994; Groot Kormelink
and Luyten, 1997).We stably transfected the cells with human7
nAChR expression vector to create SH-7 cells, which showed
abundant and saturable-BT binding. This was demonstrated by
7 receptor precipitation using biotin–-BT and streptavidin–
agarose, followed by 7 Western blot (Fig. 1) and by 125I--BT
binding (D. Feuerbach, unpublished observations). 7 nAChRs
migrated as amajor band of50 kDa (Fig. 1) and occasionally as
an additional band of 55 kDa (see Fig. 5), as observed previ-
ously in other cell lines and vertebrate brain (Drisdel and Green,
2000).
Treatment of SH-7 cells with the tyrosine phosphatase in-
hibitor pervanadate for 20min produced strong phosphorylation
of 7 receptors (Fig. 1). Preincubation of cells with the general
tyrosine kinase inhibitor genistein resulted in reduction of 7
phosphorylation in a dose-dependent way. These findings dem-
onstrate, for the first time, tyrosine phosphorylation of -BT-
binding7 nAChRs. This phosphorylation results from a balance
between tyrosine kinase and phosphatase activity and can be in-
creased by pervanadate and decreased by genistein. Interestingly,
7 nAChRphosphorylation is under dynamic regulation,with an
apparent turnover time of20 min.
Inhibition of tyrosine kinases by genistein increases 7
nAChR responses
Genisteinmodulates the activity of ligand-gated channels by both
a direct and indirect action (Jassar et al., 1997; Huang et al., 1999;
Balduzzi et al., 2002). Although direct effects are thought to arise
from an interaction with the channel itself, indirect effects stem
from inhibiting intracellular phosphorylation pathways. To ex-
amine whether genistein modulates 7 receptors and to distin-
guish between direct and indirect actions, two experimental pro-
tocols were designed and electrophysiological recordings were
performed on Xenopus oocytes expressing human 7 nAChRs.
First, we assayed the effect of coapplication of increasing
genistein concentrationswith a fixedACh test pulse (200M, 2 s).
Under these circumstances, ACh-evoked currents were slightly
increased by genistein, and the plateau phase was modified at
high genistein concentration (Fig. 2a). This reflects direct
genistein action on the 7 channel because it is very unlikely that
modification of phosphorylation pathways occurs within the
short ACh test pulse. Second, genisteinwas preapplied in increas-
ing concentration for 1–2 h, allowing it to interact with intracel-
lular tyrosine kinases. To minimize contamination by genistein
during the subsequent ACh test pulse, a brief gap of superfusion
with control buffer was introduced (1 s; see Materials and Meth-
ods). Under these conditions, ACh-evoked currents were more
strongly potentiated (Fig. 2b). We also tested shorter genistein
preincubation times, from 10 to 60 min, and found similar ef-
fects, albeit with a higher cell-to-cell variation (data not shown).
Plots of the peak of the ACh-evoked currents recorded with
the twoprotocols as a function of the genistein concentrations are
shown in Figure 2c. Genistein preapplication caused a stronger
effect than coapplication. In preapplication, 7 receptor poten-
Figure 1. Regulation of 7 receptor tyrosine phosphorylation by genistein and pervana-
date. SH-7 cells were treated for 10 min with genistein, followed by addition of 50 m
pervanadate for 20min in thepresenceofgenistein. In controls, these compoundswereomitted
or the vehicle alone (0.25% DMSO,v) was added. Cells were lysed and 7 receptors were
precipitated using biotinylated-BT and streptavidin-agarose (Tox-P). As a control, an excess
of free -BT was added before precipitation (T). Immunoblotting using phosphotyrosine-
specific antibodies, followed by7 reprobing, reveals that pervanadate causes strong7 re-
ceptor phosphorylation, which is greatly reduced by genistein. Shorter exposure times and
side-by-side alignment of blots confirmed precise overlap between phosphotyrosine and 7
signals (data not shown).
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tiation is independent of the presence of
genistein during the ACh test pulse, indi-
cating that most of this genistein effect (at
least a threefold potentiation) results from
inhibition of intracellular phosphoryla-
tion rather than direct action on the 7
channel. We thus used the preapplication
protocol for all subsequent experiments.
We noticed that the genistein effect is rap-
idly reversible. After extensively washing
oocytes for 10 min, new ACh test pulses
evoked responses of normal amplitude
and time course (data not shown). This
suggests that phosphorylation occurs rap-
idly, consistent with the rapid turnover of
7 phosphorylation detected in our bio-
chemical experiments in Figure 1.
Specificity of genistein was tested using
the biologically inactive derivative Igen.
Preapplication of Igen had no effect on
ACh-evoked currents (Fig. 2d). AChdose–
response curves revealed a significant in-
crease in the ACh-evoked response attrib-
utable to genistein at almost all ACh
concentrations, whereas Igen produced no
effect (Fig. 2e). The EC50 of ACh was not
significantly affected by genistein (supple-
mental Table 1, available at www.
jneurosci.org as supplemental material).
To rule out the possibility that
genistein potentiation of 7 responses is
restricted to receptors expressed in Xeno-
pus oocytes, electrophysiological experi-
ments were conducted in SH-7 cells.
These cells share several properties with
neurons, have endogenous 7 receptors,
and thus provide a native environment for
7 nAChRs. Fast agonist applications re-
vealed that these cells display typical ACh-
evoked currents and that brief exposure to genistein (1 min) was
sufficient to cause a significant increase of the ACh responses in
27 of the 35 cells tested (Fig. 3a). To avoid a direct effect of
genistein, cells were washed for 5 s before the ACh pulse. The
typical time course of the ACh-evoked current suggests that these
responses indeed reflect activation of 7 receptors. This was con-
firmed by the full blockade of the currents after 3min exposure to
100 nM -BT (Fig. 3a). Pooled data showed that the genistein-
induced increase inACh currentwas on average 2.3-fold (Fig. 3c).
Genistein exposure up to 3 min did not cause further potentia-
tion (n 11 trials; analyzed by paired Student’s t tests). Because
of the nature of the cell patch for recording, longer genistein
incubation times could not be tested.
To verify that native 7 nAChRs behave similarly to receptors
in SH-SY5Y cells and receptors expressed in Xenopus oocytes,
effects of genistein were assayed in 7-expressing neurons in rat
brain slices. Whole-cell recordings were performed in either hip-
pocampal interneurons located in the CA1 stratum radiatum or
magnocellular neurons located in the hypothalamic supraoptic
nucleus. Both classes of neurons express functional 7-containing
nAChRs (Alkondon et al., 1997; Jones andYakel, 1997; Frazier et al.,
1998a; Zaninetti et al., 2000, 2002). In hippocampal slices, ACh (0.2
mM) evoked a rapidly activating inward current in all nine interneu-
rons tested. Genistein potentiated the ACh-evoked current by a fac-
tor of 2.1 	 0.4 (n  4) (Fig. 4a,c). This genistein-enhanced ACh
current was sensitive to metyllycaconitine (MLA) (10 nM; n 3), a
competitive antagonist specific for 7 nAChRs (Fig. 4a). Genistein
also caused a significant increase of the current evoked by ACh (1
mM) in supraoptic magnocellular neurons (three neurons in three
different slices) (Fig. 4d,e). Such currents are known to reflect 7
receptor activity and are blocked by -BT (Zaninetti et al.,
2000). The genistein-induced potentiation was rapidly revers-
ible after removal of the drug (Fig. 4d,e).
Together, thesedata showthatgenistein treatmentpotentiates7
ACh-evoked currents. The potentiation is similar (2.1-fold to3-
fold), in oocytes, SH-SY5Ycells, andhippocampal interneurons and
occurs progressively during a 15 min incubation in supraoptic nu-
cleus slices. Potentiation does not stem from direct genistein action
on the 7 receptor channel but most likely occurs from indirect
effects, i.e., inhibition of tyrosine kinases. The potentiation is rapidly
reversible after drug wash-off in brain, SH-7 cells, and oocytes,
implying that the critical phosphorylation/dephosphorylation steps
occur with a rapid turnover shorter than 20min.
Inhibition of tyrosine phosphatases decreases 7
ACh-evoked responses
To assess the consequences of increased tyrosine phosphoryla-
tion for 7 function, we treated oocytes with pervanadate. Per-
Figure2. Genistein potentiates7 nAChRs in Xenopus oocytes. Oocytes expressing human7 nAChRswere challenged under
two-electrode voltage clamp. a, Recorded current during coapplication of ACh (200M, 2 s; filled bars) with increasing concen-
trations of genistein (open bars). b, ACh-evoked (200 M, 2 s) current before (gray traces) or after (1–2 h) incubation with
increasing concentrations of genistein (black traces). c, Genistein (Gen) dose–response curves obtained from coapplication (a,
circles, dashed line) or preincubation (b, triangles, solid line). At each genistein concentration tested, the current enhancement
recorded for 7 is much stronger in the case of preincubation than for coapplication. Data are normalized to the ACh-evoked
current recorded in absence of genistein (n 8, for all data points). The EC50 for genistein coapplication is 26 M and for
preincubation is 19M. d, Application of ACh (1 mM during 3 s) evoked a current (gray traces) that is enhanced by preincubation
with 10M genistein (black trace, left) but not with 10M Igen (black trace, right). e, ACh dose–response curve. Currents were
evoked by successive ACh test pulses (3 s) applied every 90 s, using increasing ACh concentrations. Currents were normalized to 1
at saturating concentration recorded in controls. Squares and dashed line correspond to control (n 34), circles and solid line
were recorded after genistein treatment (10M, 1–2h; n 16), and triangles correspond to Igen treatment (10M, 1–2h; n
12). Currents recorded after genistein treatments are significantly different from control, but their EC50 values are not different
(supplemental Table 1, available at www.jneurosci.org as supplemental material). For all dose–response curves, data points are
mean	 SEM. Lines correspond to the best fit obtained with a Hill equation. Significant differences were calculated by unpaired,
two-tailed Student’s t tests (p 0.001).
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vanadate pretreatment decreased the peak amplitude of ACh-
evoked currents (Fig. 5a,b), without substantially affecting
current kinetics or the EC50 of ACh (supplemental Table 1, avail-
able at www.jneurosci.org as supplemental material). The per-
vanadate preincubation time could be as short as 30 min and still
yielded decreased responses.
Reduction in current amplitude could, in principle, originate
from a relocation of surface receptors to intracellular compart-
ments or from a change in the responsiveness of the surface pop-
ulation of 7 nAChRs to ACh. To distinguish between these pos-
sibilities, we treated SH-7 cells with pervanadate and selectively
precipitated surface or internal 7 receptors using biotin–-BT
as described previously formuscle nAChRs inmyotubes (Moran-
sard et al., 2003) (for details, see Materials and Methods). 7
nAChRs were found to reside both at the surface and in intracel-
lular compartments of SH-7 cells (Fig. 5c). In untreated cells,
43 	 3% (mean 	 SEM; n  4 blots) of all 7 receptors were
located at the surface. This value is similar to oocytes expressing
7 nAChRs, in which 50% of all 7 receptors were recently
found to reside at the surface (Cho et al., 2005). In SH-7 cells,
pervanadate caused phosphorylation only of the surface 7
nAChRs and did not reduce the number of surface receptors or
alter the ratio between surface and intracellular receptors (Fig.
5c,d). Thus, pervanadate leads to phosphorylation of 7 nAChRs
selectively at the cell surface and inhibits 7 function, without
detectable change in receptor distribution. The rapid timescale of
the pervanadate effect on7 activity (30minpreincubation) (Fig.
5a,b) is consistent with the rapid turnover of7 phosphorylation
seen in Figure 1.
Mutation of cytoplasmic tyrosine
residues increases the7 nAChR
current amplitude
The effects of genistein and pervanadate
on 7 receptor function (Figs. 2–5) could
be attributed to changes in levels of ty-
rosine phosphorylation of 7 nAChRs
themselves or indirectly through (de)-
phosphorylation of other proteins. To dis-
tinguish between these possibilities, we
first identified putative tyrosine phos-
phorylation sites in the 7 protein se-
quence. Most of the intracellular receptor
portion is formed by the long cytoplasmic
loop between transmembrane domains
TM3 and TM4 (Chini et al., 1994). In hu-
man 7, this loop contains two tyrosine
residues, Tyr-386 and Tyr-442. Computer
algorithms predicted Tyr-442 as a consen-
sus phosphorylation site, whereas Tyr-386
emerged as a phosphorylation site by se-
quence comparisonwith known phospho-
tyrosines in Torpedo nAChR subunits
(Chini et al., 1994) (supplemental Fig. 1,
available at www.jneurosci.org as supple-
mental material). The residues surround-
ing Tyr-386 and Tyr-442 showed a high
degree of conservation across species
(supplemental Fig. 1, available at www.
jneurosci.org as supplemental material).
Tyr-386 is part of a consensus motif,
NXXY, for binding to phosphotyrosine-
binding domains in signaling proteins
such as the Shc family (Ware et al., 1996). Thus, Tyr-386 and
Tyr-442 are strong candidates for phosphorylation.
We therefore substituted both Tyr-386 and Tyr-442 by ala-
nine using site-directedmutagenesis. Oocytes expressing themu-
tant (7 2Y-A) receptors displayed significantly larger (2.5-
fold) ACh-evoked currents than those recorded in sibling oocytes
expressing the wild-type receptors (Fig. 6a,b). No significant dif-
ference was, however, observed for either the current kinetics or
the sensitivity to ACh (supplemental Table 1, available at www.
jneurosci.org as supplemental material). Interestingly, the maxi-
mal evoked current (Imax) of 7 2Y-A receptors was comparable
with the Imax in parallel genistein-treated cells expressing wild-
type 7 nAChRs (Fig. 6c). Importantly, the Imax of 7 2Y-A re-
ceptors was insensitive to either genistein or pervanadate treat-
ments (Fig. 6c). These data strongly suggest that the modulation
of wild-type 7 nAChRs by these compounds originates mostly
from changes in tyrosine phosphorylation of 7 receptors them-
selves. Dephosphorylation of 7 nAChRs, attributable to
genistein or mutation of tyrosines, results in receptor potentia-
tion, whereas phosphorylation, evoked by pervanadate, causes
inhibition. Tyrosine phosphorylation of 7 thus negatively regu-
lates 7 receptor activity.
SFKs interact with the cytoplasmic loop of 7 nAChRs
To examine which tyrosine kinases phosphorylate and regulate
7 nAChRs, we focused on SFKs, because they, as well as 7
receptors, can modulate synaptic plasticity in the hippocampus
(Lu et al., 1998; Ji et al., 2001). Because SFKs usually bind to their
substrates, forming a complex (Thomas and Brugge, 1997), we
first tested whether they interact with 7 receptors. We prepared
Figure 3. Genistein and PP2 potentiate ACh-evoked currents in SH-7 cells.a, Currents evoked by brief ACh test pulses (1mM,
200ms) were recorded in control conditions (left trace), after 1min exposure to 100M genistein (middle trace), and again after
1 min incubation with 100 nM -BT (right trace). Bars above the traces indicate the duration of ACh application. Dashed line
indicates the amplitude of the peak of the ACh-evoked current measured in control. b, Recordings obtained in another cell using
the same protocol but with exposure to PP2 (10M). To avoid direct effects of genistein or PP2, cells were washed for 5 s before
testing with ACh. All recordings were obtained in whole-cell patch-clamp configuration at a holding potential of100 mV. c,
Ratios between ACh-evoked currents recorded after drug treatment and before drug treatment (control), measured for 27
genistein-treated and 12 PP2-treated cells, are represented. Paired Student’s t test computations of the current amplitude
recorded after exposure to genistein or PP2 versus the valuemeasured in the same cell in control (before drug treatment) indicate
a highly significant increase attributable to both inhibitors (***p 0.001).
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lysates of SH-7 cells and precipitated 7
nAChRs using biotin–-BT, followed by
streptavidin–agarose. We identified 7
nAChR-associated SFKs by immunoblot-
ting with Src-CT (Mittaud et al., 2001), a
pan-Src antiserum reactive with several
SFKs, including Src, Fyn, and Yes. This as-
say detected specific association of mem-
bers of the Src family with 7 nAChRs
(Fig. 7a). Using antibodies specific for sin-
gle SFKs, we identified Src, Fyn, and Lyn as
7-associated kinases. These interactions
were specific, because addition of free ex-
cess -BT to the lysates decreased the sig-
nal and because no specific association oc-
curred between 7 nAChRs and G
subunits of trimeric G-proteins or Yes, de-
spite the expression of these proteins in
SH-7 cells (Fig. 7a and data not shown).
SH-7 cells express functional 7 re-
ceptor channels at the surface (Fig. 3). To
determine whether such receptors interact
with SFKs, we selectively isolated surface
7 nAChRs from SH-7 cells by adding
biotin–-BT to intact cells before lysis and
indeed found associated SFKs (Fig. 7b).
The amount of SFKs on surface 7 recep-
tors was comparable with the amount of
SFKs on total 7 nAChRs, suggesting that
SFKs preferentially bind to 7 receptors at
the cell surface (Fig. 7b).
To verify SFK interaction with func-
tional 7 nAChRs in vivo, we used rat
brain, in which -BT-binding receptors
consist of7 subunits in homomeric com-
plexes (Drisdel and Green, 2000). We pre-
pared brain extracts from P5 and P30 rats,
precipitated 7 receptor with -BT cou-
pled to Sepharose beads (Drisdel and
Green, 2000), and detected specific associ-
ation with SFKs (Fig. 7c). Thus, in both rat
brain and human SH-7 cells, -BT-
binding 7 nAChRs interact with mem-
bers of the Src family.
Furthermore, we mapped the site on 7
for SFK interaction using bacterially ex-
pressed and purified GST fusion proteins
(Fuhrer andHall, 1996) containing portions of human7 receptor.
GST fusionproteins, attached to glutathione–Sepharose beads,were
added to lysates of SH-7 cells, andassociationof SFKswas analyzed
by precipitation and Western blotting using pan-Src antibodies. In
these pull-down assays, SFKs from SH-7 cell extracts interacted
with the 7 loop (GST-7loop protein) but not with an 7 portion
comprising transmembrane domain TM4 and the C terminus
(GST-7TM4CT protein) (Fig. 7d). As an additional control, SFKs
did not interact with parental GST protein (Fig. 7d). In demonstrat-
ing interaction between SFKs and the7 receptor loop, these exper-
iments confirm the specific7-SFKassociation shownby coprecipi-
tation using -BT (Fig. 7a–c).
Collectively, these data demonstrate that functional, -BT-
binding surface7 nAChRs interact with SFKs.Most likely, these
kinases bind by a direct protein–protein interaction to the intra-
cellular loop between TM3 and TM4.
SFKs phosphorylate 7 nAChRs at the plasma membrane
To determine whether SFKs not only bind to but phosphorylate
7 receptors, we used the Src-family-specific inhibitors PP2
(Smith et al., 2001) and CGP77675 (Missbach et al., 1999; Mit-
taud et al., 2004). In SH-7 cells treated with these compounds,
pervanadate did not cause efficient phosphorylation of 7
nAChRs, as shown by biotin–-BT and streptavidin–agarose
precipitation, followed by phosphotyrosine immunoblotting
(Fig. 8a,b). In SH-7 cell lysates analyzed without precipitation,
phosphorylation of other cellular proteins still occurred in the
presence of CGP77675 and pervanadate, showing specificity of
the SFK-mediated 7 receptor phosphorylation process (Fig.
8a,b). Use of another SFK-specific inhibitor, SU6656 (Blake et al.,
2000), yielded the same result (data not shown). Thus, SFKs can
specifically phosphorylate functional, -BT-binding 7 recep-
tors in SH-7 cells. It appears that SFK-mediated phosphoryla-
Figure 4. Genistein and specific SFK inhibitors potentiate native 7 nAChRs. a– c, Effect of genistein and of specific SFK
inhibitors on hippocampal CA1 interneurons. a represents current traces evoked by brief ACh pulses (0.2 mM; see Materials and
Methods) in control conditions (top trace), after genistein application (100m,20min;middle trace), and in the presence ofMLA
(10nM;bottomtrace). Genistein causes an increaseof theAChpeak current, andMLAabolishes theACh response.b, Current traces,
recorded in another hippocampal interneuron and showing the ACh-evoked current in control conditions (top trace) and after
applicationofPP2 (10M) for 20and96min (middle andbottomtraces, respectively). PP2had tobeapplied for a longer time than
genistein before observing a significant potentiation. c, Histogram showing themean effects of genistein (100M), PP2 (10M),
and SU6656 (0.5M) on the ACh-evoked current in hippocampal interneurons. Numbers indicate the number of neurons ana-
lyzed. d, e, Effect of genistein on the ACh-evoked current in magnocellular supraoptic neurons. d represents the mean current
traces (n 3) evoked by ACh pulses (1mM) in control conditions (left trace), after genistein application (100M, 15min; middle
trace), and after a 10min recovery (right trace). e, Peak amplitude of ACh-evoked currents (squares) plotted in absolute value as
a functionof the recording time. Genisteinwas added to theperfusion solution for the15minperiod representedby thehorizontal
gray bar. Lines through the data points are exponential best fits. Note that, despite a progressive decrease in theAChpeak current,
probably attributable to receptor desensitization and run down, genistein markedly and reversibly increased the ACh response.
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tion occurs rapidly, because a 20 min pervanadate treatment is
sufficient to visualize it (Fig. 8a,b).
SFK-mediated 7 receptor phosphorylation occurred at the
plasma membrane, because CGP77675 blocked pervanadate-
induced phosphorylation of surface 7 receptors (Fig. 5c). Fur-
thermore, CGP77675 treatment (when combined with pervana-
date) did not affect the number of surface or internal 7 nAChRs
(Fig. 5c,d), implying that SFK activity does not affect receptor
distribution in SH-7 cells.
We also used GST-7loop protein to assess phosphorylation
of the two consensus tyrosine sites by SFKs. In the first approach,
GST-7loop protein was added to lysates prepared from
pervanadate- and PP2-treated SH-7 cells. After pull-down,
complexes were subjected to in vitro phosphorylation in the pres-
ence of ATP. Without PP2, GST-7loop protein was phosphor-
ylated as shown by phosphotyrosine immunoblotting (Fig. 8c).
PP2 reduced this signal, revealing that SFKs from SH-7 cells
phosphorylated the 7 loop in the assay (Fig. 8c). This was ob-
served for GST fusion proteins containing the human 7 loop
(Fig. 8c) or the rat loop sequence (data not shown). In the second
approach, wild-type and mutant forms of GST-7loop protein,
lacking Tyr-386 and/or Tyr-442, were incubated with purified
Src kinase. Wild-type and single mutants, but not the double
mutant, were phosphorylated, illustrating that Src can phosphor-
ylate both tyrosines within the7 receptor loop (Fig. 8d). In both
approaches, a 15 min incubation produced strong in vitro phos-
phorylation. This rapid phosphorylation suggests that the 7
nAChR is a direct substrate for SFKs.
SFKs regulate7 receptor function
To determine the effect of SFKs on 7 re-
ceptor function, we used PP2 and SU6656
on oocytes expressing wild-type human
7 nAChRs. Oocytes were first challenged
with brief ACh test pulses (1.25 mM, 1 s)
that evoked control currents of maximal
amplitude and then incubated for 1 h or
longer with either SU6656 or PP2. ACh-
evoked currents were recorded again at the
end of the incubation using the same pulse
parameters. Plots of the ratio between the
ACh-evoked currents after and before
drug incubation are shown in Figure 9a. A
significant increase in the ACh-evoked
current was observed after incubation
with SU6656 and PP2 but was absent for
cells treated with control solution or with
the inactive PP3 analog. In agreement with
a dephosphorylation-dependent increase
of the wild-type 7 receptor activity, none
of the compounds tested significantly
modified the amplitude of the ACh-
evoked currents recorded in oocytes ex-
pressing the 7–2YA mutant receptor
(Fig. 9a). Thus, inhibiting SFKs increases
the 7 nAChR activity, attributable to de-
creased phosphorylation of 7 receptors
themselves.
We analyzed the effect of PP2 on ACh-
evoked currents in SH-7 cells. PP2 expo-
sure caused a significant increase of the
current in 12 of 15 cells tested (Fig. 3b,c)
(determined by paired student’s t tests).
When comparedwith parallel experiments
using genistein, the PP2-induced increase was smaller (Fig. 3b,c),
similar to the situation in oocytes.
We verified these findings for native7 receptors by analyzing
the effect of PP2 and SU6656 on ACh-evoked 7 nAChR re-
sponses in the hippocampus. Whole-cell recordings of CA1 stra-
tum radiatum interneurons were performed in rat hippocampal
slices, using 0.2 mM ACh test pulses. Incubation with PP2 (n 2
interneurons) or SU6656 (n  3 interneurons) for periods
longer than 1 h caused a significant increase in ACh-evoked
inward current, by factors of 1.6 (PP2) and 1.4	 0.3 (SU6656)
(Fig. 4b,c).
Together, SFK inhibitors significantly potentiate 7 re-
sponses, most likely by receptor dephosphorylation. The effects
are consistently smaller in the three preparations tested (oocytes,
SH-7 cells, and hippocampal interneurons) when compared
with genistein, suggesting that, besides the Src family, other ki-
nases act on 7 nAChRs.
In a gain-of-function approach, we coexpressed human wild-
type 7 nAChRs in oocytes together with vSrc, a constitutively
active form of Src. Functionally, vSrc corresponds to maximally
activated Src kinase in which all inhibitory intramolecular inter-
actions are displaced, leading to open kinase conformation and
maximal kinase activity (Thomas and Brugge, 1997). vSrc has
therefore been widely used to study regulation of ion channels by
SFKs, often in the Xenopus oocyte expression system, and is a
model molecule for the fully active cellular Src kinase (Holmes et
al., 1996b; Nitabach et al., 2001, 2002).
We observed a significant reduction of the ACh-evoked cur-
Figure5. Pervanadate inhibits human7 nAChRs in Xenopus oocytes.a, ACh-evoked (1mM, 3 s) currentwithout (left) or after
0.5–1h incubationwith50Mpervanadate (perv, right).b, AChdose–response curvewithout (squares, dashed line;n28) and
after pervanadate treatment (crosses, solid line; n 22). Currentswere evoked by successive test pulses (3 s)with increasing ACh
concentrations, applied every 90 s. Currents were normalized to 1 at saturating ACh concentration (no perv). Data points are
expressed as mean	 SEM, and the lines correspond to the best fit with a Hill equation (supplemental Table 1, available at
www.jneurosci.org as supplemental material). Significant differences between pervanadate and control treatments were calcu-
latedbyunpaired, two-tailed Student’s t tests (*p0.01). c, SH-7 cellswere treated for 90minwith10MCGP77675, followed
by addition of 50 m pervanadate. In controls, these compounds were omitted or an excess of free -BT was added before
precipitation (T). Intracellular or surface7 receptors were precipitated using biotinylated-BT and analyzed by phosphoty-
rosine and7 immunoblotting. Pervanadate causes phosphorylation of surface but not internal7 receptors, and this phosphor-
ylation originates from SFKs. Pervanadate, alone or with CGP77675, does not decrease the number of surface 7 receptors or
affect internal7. d,7 blots as shown in cwere quantitated by densitometric scanning (mean	 SD; n 10).
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rent in oocytes coinjected with 7 receptor and the vSrc expres-
sion vector (Fig. 9b), without noticeable changes in the kinetics of
the responses (data not shown). The reduction in Imax by vSrcwas
comparable with that caused by pervanadate treatment (Fig. 5c).
As a control for nonspecific side effects of kinase expression,
coinjection of a vSrc mutant (vSrc-KD), lacking kinase activity
attributable to a point mutation in the ATP-binding site (Nit-
abach et al., 2001, 2002), produced no effect (Fig. 9b).
SFKs are antagonized by phosphatases
Thepervanadate data show that7 is a substrate for phosphatases
and that 7 phosphorylation has a rapid turnover time (20
min) revealing dynamic regulation by kinases and phosphatases
(Fig. 1). The increased activity attributable to genistein, SU6656,
or PP2 stems primarily from dephosphorylation of 7 receptors
themselves, because 7 2Y-A receptors are not regulated by these
compounds (Figs. 6, 9). Thus, in steady state, the balance between
phosphatases and kinases, including SFKs, appears to produce a
certain level of basal tyrosine phosphorylation of 7 nAChRs.
Our biochemical assays are, however, not sensitive enough to
visualize basal7 phosphorylation (Fig. 1). This most likely orig-
inates from persistent phosphatase activity that dephosphory-
lates 7 receptors during the precipitation with -BT. Several
considerations support this hypothesis. First, in SH-7 cells, 7
phosphorylation is unstable with rapid turnover. The overall
phosphatase activity is pronounced as evidenced by the high level
of dephosphorylation, because a 20 min pervanadate treatment
produces strong 7 phosphorylation (Fig. 1). Second, although
our lysis buffer contains an excess of phosphatase inhibitors (see
Materials and Methods), phosphatase activity cannot be com-
pletely inactivated in the lysates and is present during the precip-
itation with -BT. Over the course of several trial experiments,
we have observed that, in lysates made from pervanadate-treated
SH-7 cells, an extension of the biotin–-BT/streptavidin–aga-
rose precipitation time (normal duration, 2 h) significantly de-
creases the 7 phosphorylation signal without changing the
amount of 7 protein (A. Wiesner and C. Fuhrer, unpublished
observations). Third, some of the phosphatases acting on7may
be associated with the receptor because, in adrenal medulla chro-
maffin cells, ganglionic-type nAChRs associate with phospha-
tases in a complex (van Hoek et al., 1997). Such association will
increase the efficiency of receptor dephosphorylation andmake it
hard to block this process during 7 precipitation. Finally,
shaker-type voltage-gated potassium channels are also associated
and negatively regulated by Src through tyrosine phosphoryla-
tion (Holmes et al., 1996a; Nitabach et al., 2002). Tyrosine phos-
phatases act on these channels, such that their basal tyrosine
phosphorylation level is low or undetectable in a Western blot,
whereas pervanadate leads to strong channel phosphorylation
(Holmes et al., 1996a; Nitabach et al., 2002). The similarity to 7
nAChRs suggests that phosphatase regulation of ion channels
may be widespread, antagonize SFKs, and render detection of
basal channel phosphorylation difficult.
Together, our data show that increasing 7 receptor phos-
phorylation by activation of Src or by inactivation of tyrosine
phosphatases yields a comparable inhibitory effect on the ACh-
evoked currents (Figs. 5, 9). Conversely, decreasing 7 nAChR
phosphorylation through inhibition of SFKs causes potentiation
of the ACh-triggered response (Figs. 3, 4, 9). Thus, SFKs are
counteracted by phosphatases in phosphorylation of 7 recep-
tors, and these kinases modulate the functional activity of 7
nAChRs.
Figure 6. 7 2Y-Amutant nAChRs exhibit larger ACh-evoked currents comparedwithwild-
type 7. Xenopus oocytes expressing wild-type or 7 2Y-A (Y386A, Y442A) receptor were
recorded using two-electrode voltage clamp. a, ACh-evoked currents for wild-type andmutant
7 nAChRs. Increasing ACh concentrations are indicated and expressed in micromolar. b, ACh
dose–response curves for wild-type 7 (squares, dashed line; n 63) and mutant 7 2Y-A
receptors (triangle, solid line;n 34). Currentswere evokedby successive test pulses (3 s)with
increasing ACh concentrations, applied every 90 s. Lines through the data points correspond to
the best fit with a Hill equation (supplemental Table 1, available at www.jneurosci.org as
supplemental material). c, Maximal recorded currents (Imax) were plotted as a function of the
drug applied at wild-type 7 (open bars) or 7 2Y-A mutant receptor (gray bars). Genistein
(gen) and genistin (igen) concentrationswere 10M. The numbers in parentheses indicate the
number of cells tested in each condition. Data are expressed as mean	 SEM and show that
ACh-evoked currents are higher for7 2Y-A nAChRs and that these receptors are insensitive to
genistein and pervanadate (perv) treatment. Significant differences were calculated by un-
paired, two-tailed Student’s t tests (*p 0.01;p 0.001).
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Kinase inhibition does not change amount and clustering of
7 receptors at the cell surface
The increase in current amplitude observed after genistein or PP2
preincubation could be attributed either to an increase in the
number of receptors present at the cell surface or to a modifica-
tion of the receptor properties. Cho et al. (2005) have recently
reported that, in Xenopus oocytes expressing rat 7 nAChRs,
50% of all receptors reside in intracellular compartments.
Genistein caused SNARE (soluble N-ethylmaleimide-sensitive
factor attachment protein receptor)-dependent insertion of
some of these receptors into the plasma membrane, leading to a
twofold increase in the amplitude of ACh-evoked currents, and
this also occurred for mutant receptors lacking cytoplasmic ty-
rosines (Cho et al., 2005). We therefore determined, after
genistein treatment, the level of surface receptors in oocytes by
labeling with a saturating dose (10 nM) of 125I--BT. Data pre-
sented in Figure 10a illustrate that genistein incubation does not
cause a significant increase in the amount of radioactive labeling
for wild-type 7 receptors. In oocytes expressing 7 2Y-A recep-
tors, more labeling was observed for both untreated and
genistein-treated oocytes (Fig. 10a). However, given the broad
range of expression levels between oocytes, well known from
other studies (Yoshii et al., 1987; Corrin-
ger et al., 1999; Cruz-Martin et al., 2001),
differences between wild-type and mutant
receptors and genistein-treated and un-
treated cells remained nonsignificant.
We obtained very similar results in
SH-7 cells, because treatment with
genistein, PP2, or pervanadate did not
change the amount of surface7 receptors
as determined by labeling with 125I--BT
(Fig. 10b). We also precipitated, using
biotin–-BT, intracellular or surface 7
receptors from these cells (as described be-
fore for Fig. 5) and found no increase in
the amount of surface receptors when cells
were treated with genistein or PP2 (Fig.
10c,d). Finally, intact SH-7 cells were la-
beled with Alexa 488–-BT and examined
by fluorescence microscopy to visualize
surface 7 receptors. Receptors were visi-
ble as clusters on cellular processes and the
soma. Some of these clusters appear to be
on small filopodiae emanating from the
processes (Fig. 10e). The distribution of7
receptor clusters on soma, processes, and
filopodiae is very similar to hippocampal
GABAergic interneurons (Kawai et al.,
2002). Importantly, genistein and PP2
treatment did not produce any obvious
changes in the number, size, intensity, or
distribution of 7 clusters (Fig. 10e).
Collectively, these data demonstrate that
genistein and PP2 do not significantly affect
the amount or distribution of7 receptor at
the surface of SH-7 cells. However, the
same genistein or PP2 treatments signifi-
cantly increase ACh-evoked current of 7
receptors in oocytes, SH-7 cells, and hip-
pocampal interneurons (Figs. 2–4, 9). This
increase, thus, does not stem from increased
numbers of receptors at the surface but from
amodificationof theproperties of7nAChRspresent in theplasma
membrane.
Discussion
In this work, we have examined the effects of tyrosine phosphoryla-
tion on nicotinic receptors in theCNS, focusing on7 nAChRs.We
found that7 receptors are rapidlyphosphorylated anddephospho-
rylated and that dephosphorylated receptors aremore active. Part of
the responsible kinases are SFKs, because they bind and phosphor-
ylate 7 nAChRs at the cell surface and modulate their functional
properties. The balance between SFKs andphosphatases determines
the net phosphorylation of 7 nAChRs, constituting an important
regulatory mechanism for the activity of receptors at the plasma
membrane and offering an additional capacity for modulation of
neuronal network functions.
Changes in7 nAChR phosphorylation modulate
receptor activity
Dephosphorylation of 7 receptors was achieved by genistein
treatment. Although we observed that genistein causes at least
two effects on the 7 functional activity in oocytes, we found
strong potentiation of ACh-evoked currents after prolonged
Figure7. 7nAChRs interactwith SFKs.a,7 receptorswere precipitated fromSH-7 cells using biotinylated-BT followed
by streptavidin–agarose (Tox-P), and associated proteins were identified by immunoblotting. As controls, excess free-BT was
added before precipitation (T), or a fraction of the lysate was analyzedwithout precipitation (Lys.). Pan-Src (Src-CT) and single
kinase-specific antibodies show that7 receptors associatewith SFKs, including Src, Fyn, and Lyn,whereas no specific association
occurswith the G subunit of trimeric G-proteins.b, Surface or total7 receptorswere precipitated fromSH-7 cells and probed
with Src-CT antibodies, showing that the association of7nAChRswith SFKs is prominent at the cell surface. c,Whole brains of P5
rats and forebrains of P30 ratswerehomogenized inNP-40-containingbuffer, and7 receptorswere isolatedusing-BT coupled
to Sepharose beads. Src-CT blotting reveals specific association of7 nAChRswith SFKs in brain.d, Lysates fromSH-7 cellswere
incubated with glutathione bead-bound GST-fusion proteins containing either the 7 loop (GST-7loop) or the fourth trans-
membranedomain andC-terminal rest (GST-7 TM4CT). Src-CT blotting of precipitatedbeads shows that SFKs bind specifically to
the7 loop. Arrowheads indicate the GST fusion proteins, and the asterisk denotes degradation products of GST-7loop.
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genistein treatment followed by a brief
wash. Because genistein was removed dur-
ing the ACh test pulse, we conclude that
potentiation is attributable to inhibition of
intracellular phosphorylation rather than
direct genistein action on the nAChRs.
ACh dose–response curves confirmed 7
receptor potentiation at all ACh concen-
trations after genistein preapplication but
revealed little if any change in receptor
sensitivity to ACh. In addition, the in-
crease in current amplitude was not mod-
ified by BAPTA treatment, a condition
known to minimize the contamination by
calcium-activated chloride channels
(Devillers-Thiery et al., 1992), further im-
plying that genisteinmodulates7 nAChR
activity through amore directmechanism,
most likely phosphorylation. Importantly,
we found comparable genistein potentia-
tion of 7 responses in neuroblastoma
cells, hippocampal CA1 interneurons, and
supraoptic magnocellular neurons.
Confirming the genistein effect, mu-
tant 7 2Y-A receptors displayed a poten-
tiation comparable with that of wild-type
receptors in genistein-treated cells, and the
activity of 7 2Y-A receptors was not af-
fected by genistein or pervanadate. Finally,
the importance of phosphorylation for 7
nAChR activity was demonstrated with per-
vanadate treatment. This caused decreased
receptor activity that we attributed to an in-
crease in 7 phosphorylation. Collectively,
the data suggest that tyrosine phosphoryla-
tion of 7 nAChRs negatively regulates re-
ceptor activity.
SFKs phosphorylate and regulate the
activity of7 nAChRs and are
antagonized by tyrosine phosphatases
We identified SFKs as tyrosine kinases that interact with the 7
loop and phosphorylate the receptor at the cell surface. Thereby,
SFKs are positioned to functionally modulate 7 nAChRs, and
we indeed found increased7activityduring treatmentwith specific
SFK inhibitors, PP2 and SU6656 (supplemental Fig. 2, available at
www.jneurosci.org as supplemental material). Conversely, coex-
pression of 7 nAChRs with vSrc reduced amplitudes of ACh-
evoked currents in a manner similar to pervanadate.
Although PP2 and SU6656 caused a significant increase of the
7 ACh-evoked currents, their effects were smaller than
genistein. This was observed in oocytes, SH-7 cells, and hip-
pocampal slices. Because genistein is a broad-spectrum tyrosine
kinase inhibitor and interferes with additional kinases besides
SFKs (Akiyama et al., 1987), these data suggest that 7 receptors
are also substrates for other yet unknown tyrosine kinases.
The effects of pervanadate show that 7 nAChR phosphory-
lation has a rapid turnover time of20 min, revealing dynamic
regulation by kinases and phosphatases. In such a manner, phos-
phatases could antagonize SFKs and be important control players
to determine overall 7 receptor activity. Differences in SFK
and/or phosphatase activities between tissue types could lead to
greatly different 7 responses and differences in their regulation
in various cell types.
Mechanism of7 modulation by phosphorylation: an effect
on receptor function but not number
To interpret how phosphorylation may modulate 7 receptor
activity, it is helpful to recall the principle of allosteric modula-
tion. As shown previously for calcium, ivermectin, or
5-hydroxyindole, increase of the ACh-evoked current is accom-
panied by an increase in receptor sensitivity and apparent coop-
erativity that are the signatures of positive allosteric effectors
(Galzi et al., 1996; Krause et al., 1998). Our observed lack of
modification of 7 receptor sensitivity and cooperativity there-
fore suggests that reduced 7 nAChR phosphorylation by
genistein does not act as a classical positive allosteric modulator.
Alternative hypotheses include modulation of single-channel
properties or increase in the number of responsive (activatable)
receptors. Although our data do not reveal obvious changes in
response time course, a way to discriminate between these two
hypotheses would be to record single-channel activity in different
phosphorylation conditions. Technical difficulties and single-
channel rundown prevents, however, reliable single 7 channel
Figure8. SFKs phosphorylate tyrosine residues in the7 loop.a,b, SH-7 cellswere treated for 10minwith PP2 or for 45min
withCGP77675, followedbyadditionof 50Mpervanadate for 20min in thepresenceof theSFK inhibitors.-BT-precipitated7
was analyzed by phosphotyrosine and 7 immunoblotting. Fractions of lysates were analyzed without precipitation in b.
Pervanadate-induced phosphorylation of7 nAChRs is reduced by the SFK inhibitors PP2 or CGP77675, showing that SFKs can
phosphorylate 7 receptors within SH-7 cells. c, SH-7 cells were treated with PP2 and pervanadate as in a, lysed, and
incubated with bead-bound GST-7loop fusion protein or control GST. After precipitation and washing, bead complexes (con-
taining GST fusions and associated proteins, including SFKs) were subjected to in vitro phosphorylation (IVP) reactions in the
presence of ATP at 4°C or 37°C. Bead complexes were analyzed by phosphotyrosine and Src-CT immunoblotting, showing that
pervanadate-activated SH-7 cell lysates phosphorylate GST-7loop proteins and that this phosphorylation originates from
SFKs. d, Purified GST-fusion proteins containing the7 wild-type loop or mutants in which Tyr-386 and/or Tyr-442 are replaced
by alanine were incubated with purified human Src kinase. In vitro phosphorylation was assessed in the presence of ATP at
4°C or 37°C, with or without PP2. Phosphotyrosine blotting of reaction products shows that Src phosphorylates both
tyrosines in the 7 loop.
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measurements to be done over time (Alkondon et al., 1994; Buis-
son et al., 1996; Liu and Berg, 1999).
We find that the number and clustering of receptors at the
surface of oocytes and SH-7 cells is not significantlymodified by
phosphorylation. Thus, genistein- andPP2-induced potentiation
of7 nAChRs responsesmust stem frommechanisms other than
insertionof additional receptors into thecellmembrane.Most likely,
phosphorylation affects the number of activatable receptors within
the plasmamembrane such that dephosphorylated receptors are re-
sponsive, whereas phosphorylated receptors are probably nonre-
sponsive (supplemental Fig. 2, available at www.jneurosci.org as
supplementalmaterial). In agreement with this hypothesis, mean
current amplitudes observed for 7 2Y-A receptors are signifi-
cantly larger without changes in response time course.
Cho et al. (2005) have recently found a twofold genistein-
induced receptor potentiation in oocytes that occurs also for
tyrosine-mutated receptors and was attributed to new surface
receptor insertion. Although the reasons for the differences be-
tween this and our study remain unclear, the following aspect
deserves attention. Like in the Cho et al. study, higher genistein
concentrations potentiate7 responses in oocytes threefold up to
fivefold. The magnitude of such potentiation is incompatible
with the sole hypothesis of receptor insertion. Namely, because
only 50%of all receptors are internal (Cho et al., 2005), this could
account for at most a twofold potentiation. Therefore, additional
mechanisms independent of receptor trafficking must exist, and
our data provide first evidences for thesemechanisms. This novel
hypothesis is supported by various observations (Fig. 10), most
importantly by the absence of significant increase in receptor
number, detected using 125I--BT, in both genistein-treated oo-
cytes and SH-7 cells.
Previously, phosphorylation was described for nAChRs in the
periphery. Phosphorylation on tyrosine or serine/threonine of
Torpedo electric organ receptors to a high stoichiometry in vitro
causes subtle changes in desensitization ki-
netics but not in Imax (Huganir et al., 1986;
Hopfield et al., 1988). In adrenal medulla
chromaffin cells, Src potentiates
ganglionic-type heteromeric nAChRs in
the secretion of catecholamines (Wang et
al., 2004). In mammalian muscle, SFKs in-
teract with the nAChR (Fuhrer and Hall,
1996) and play a role in clustering of
nAChRs at the endplate (Mittaud et al.,
2001, 2004; Mohamed et al., 2001; Smith et
al., 2001). Thus, phosphorylation and SFKs
affect peripheral nAChRs in many differ-
ent ways, depending on tissue, subunit-
type of nAChRs, and functional role of the
receptors.
Possible roles of SFKs and tyrosine
phosphorylation of 7 receptors in CNS
neural circuits
Because SFK and phosphatase activities are
highly regulated by different signals
(Thomas and Brugge, 1997), the control of
theend levelofphosphorylationoffers apos-
sibility of fine-tuning 7 receptor activity.
This could play a role in various7 nAChR-
mediated processes. At the cellular and syn-
aptic level, calcium influx through7 recep-
tors activates various downstream signaling
pathways (Dajas-Bailador and Wonnacott, 2004). To control such
activation and avoid calcium toxicity, the activity of 7 receptors
must be precisely controlled andmay involve (de)phosphorylation.
At the neuronal circuit level, it is interesting that phosphory-
lated 7 nAChRs are less active: this is in contrast to NMDA
receptors, which are potentiated by Src and tyrosine phosphory-
lation (Yu et al., 1997), but similar to shaker-type voltage-gated
potassium channels, which are inhibited by vSrc (Holmes et al.,
1996b; Nitabach et al., 2002). 7 nAChRs and NMDA receptors
have some overlapping functions, because both receptors are
highly permeable for calcium and important in CA1 hippocam-
pal LTP (Lu et al., 1998; Dani, 2001; Ji et al., 2001). SFK activation
may thus act in LTP induction in several ways: by potentiating
NMDA receptors in pyramidal cells (Lu et al., 1998) and by con-
comitantly inhibiting postsynaptic 7 nAChRs in GABAergic in-
terneurons, thereby facilitating disinhibition of pyramidal cells.
Such a model is supported by our finding that SFK inhibition in
hippocampal slices increases the 7 receptor activity in CA1 in-
terneurons. The activity of postsynaptic 7 receptors on hip-
pocampal inhibitory interneurons is also linked to auditory gating
(Jones et al., 1999; Martin et al., 2004). It would be interesting to
determine whether 7 phosphorylation influences the gating pro-
cess, changes of which are strongly associated with schizophrenia.
Regulationbyphosphorylationmayalsobe important forpresynap-
tic 7 nAChRs that control neurotransmitter release.
Such mechanisms, using presynaptic and/or postsynaptic 7
nAChRs, can allow neurons to regulate the weight of their syn-
aptic transmission, allow neural circuits to undergo plasticity,
and fine-tune neuronal survival. In this sense, 7 phosphoryla-
tionmechanisms could be seen as a higher hierarchical possibility
tomodulate activity and signaling in neural networks. Suchmod-
ulation may form a basis for the various emerging roles of 7
nAChRs from synaptic to systems level, including addiction,
memory, and neurological disease.
Figure9. SFKs regulate7nAChR responses.a, SFK-inhibitors SU6656 andPP2 increase theACh-evoked currents inwild-type
but not mutant7 nAChRs. ACh-evoked currents were recorded in Xenopus oocytes expressing either wild-type human7 (7
wt) or the human7–2YA mutant receptor before and after 1 h incubation with the indicated kinase inhibitor. Ratios between
currents recorded after drug treatment and before treatment, measured in a series of cells from two oocyte batches, are repre-
sented. n represents the number of cells tested in each condition. Asterisks indicate statistically significant results (comparedwith
no drug control), and error bars correspond to SEM (*p 0.007; **p 0.002; ***p 0.001, by Student’s t tests, using two
samples with unequal variance and two-tail distribution). b, DNA expression vectors encoding vSrc or viral Src kinase without
phosphorylation activity (vSrc-KD) were coinjected with human7 nAChR vector in Xenopus oocytes. Imax, evoked by 1 mM ACh
during2 s, is reducedbymore than50%whenvSrc is present comparedwith Imax in control, butnoeffect is observedwhenvSrc-KD
is coexpressed. Data are expressed asmean	 SEM. The number of cells tested is indicated in parentheses. Significant differences
were calculated by unpaired, two-tailed Student’s t tests (*p 0.01; †p 0.05).
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Washed cells were lysed, and radioactivity was quantitated by gamma counting. Nonspecific binding was assessed by adding 1
M unlabeled -BT and subtracted. Inhibitors do not affect levels of surface 7 receptors (mean	 SD; 4 experiments). c, d,
SH-7 cells were incubated with 100 M genistein or 10 M PP2, and surface or internal receptors were precipitated with
biotin--BT (Tox-P) as detailed in Materials and Methods.7 immunoblotting (c) and quantitation of blots from three experi-
ments by densitometric scanning (d) reveal no increase in the amount of surface receptors attributable to genistein or PP2.T,
Addition of 10M free-BT to cell lysates abolishes the7 signal. e, SH-7 cells were incubated with Alexa 488-coupled-BT
to stain surface 7 receptors. Fluorescence microscopy identifies many small (1m) 7 clusters on soma and cellular pro-
cesses (arrowheads). Soma (asterisks) were identified by DAPI nuclear staining (data not shown). Genistein (100M) or PP2 (10
M) treatment does not affect number, size, intensity, or distribution of clusters.
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